SAM
Security Asset Management Portfolio holdings
AUM
$171M
This Quarter Return
+4.38%
1 Year Return
-5.65%
3 Year Return
+67.36%
5 Year Return
+109.12%
10 Year Return
–
AUM
$134M
AUM Growth
+$134M
(+1.1%)
Cap. Flow
-$2.35M
Cap. Flow
% of AUM
-1.75%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
82
New
2
Increased
31
Reduced
28
Closed
1
Top Buys
| 1 |
Equinix
EQIX
|
$1.97M |
| 2 |
Dover
DOV
|
$1.88M |
| 3 |
Fiserv
FI
|
$1.09M |
| 4 |
West Pharmaceutical
WST
|
$770K |
| 5 |
Markel Group
MKL
|
$179K |
Top Sells
| 1 |
Wells Fargo
WFC
|
$2.23M |
| 2 |
Netflix
NFLX
|
$1.98M |
| 3 |
Novo Nordisk
NVO
|
$1.82M |
| 4 |
Meta Platforms (Facebook)
META
|
$418K |
| 5 |
Idexx Laboratories
IDXX
|
$347K |
Sector Composition
| 1 | Financials | 23.15% |
| 2 | Healthcare | 19.19% |
| 3 | Communication Services | 10.93% |
| 4 | Technology | 9.67% |
| 5 | Consumer Discretionary | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Markel Group
MKL
$24.5B
| $2.02M | 1.51% |
1,724
+153
| +10% | +$179K |
|
|
WP
27
DELISTED
Worldpay, Inc.
WP
| $2.02M | 1.5% |
24,501
-80
| -0.3% | -$6.58K |
|
|
28
Equinix
EQIX
$75.6B
| $1.97M | 1.47% |
+4,710
| New | +$1.97M |
|
|
RDS.A
29
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.89M | 1.41% |
29,582
| – | – |
|
|
30
Dover
DOV
$24B
| $1.88M | 1.4% |
+19,132
| New | +$1.88M |
|
31
Teradyne
TER
$18.9B
| $1.8M | 1.34% |
39,335
-225
| -0.6% | -$10.3K |
|
32
Teleflex
TFX
$5.54B
| $1.7M | 1.27% |
6,653
+120
| +2% | +$30.6K |
|
|
33
West Pharmaceutical
WST
$17.4B
| $1.68M | 1.26% |
19,079
+8,729
| +84% | +$770K |
|
|
ZAYO
34
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.65M | 1.23% |
48,430
+2,200
| +5% | +$75.1K |
|
35
3M
MMM
$82B
| $1.51M | 1.12% |
6,861
+160
| +2% | +$35.1K |
|
36
Home Depot
HD
$406B
| $1.49M | 1.11% |
8,332
+295
| +4% | +$52.6K |
|
37
AbbVie
ABBV
$373B
| $1.47M | 1.1% |
15,530
-900
| -5% | -$85.2K |
|
38
Philip Morris
PM
$261B
| $1.41M | 1.06% |
14,229
-1,144
| -7% | -$114K |
|
39
Abbott
ABT
$228B
| $1.35M | 1% |
22,453
+320
| +1% | +$19.2K |
|
40
Xylem
XYL
$34B
| $1.31M | 0.98% |
17,085
+350
| +2% | +$26.9K |
|
41
Exxon Mobil
XOM
$490B
| $1.31M | 0.97% |
17,491
+365
| +2% | +$27.2K |
|
42
Procter & Gamble
PG
$370B
| $1.3M | 0.97% |
16,374
+176
| +1% | +$14K |
|
43
Altria Group
MO
$113B
| $1.25M | 0.93% |
20,073
-1,779
| -8% | -$111K |
|
44
Microsoft
MSFT
$3.72T
| $1.23M | 0.92% |
13,483
+200
| +2% | +$18.3K |
|
45
Berkshire Hathaway Class B
BRK.B
$1.08T
| $971K | 0.72% |
4,869
+138
| +3% | +$27.5K |
|
46
VF Corp
VFC
$5.82B
| $771K | 0.58% |
10,407
| – | – |
|
47
Pfizer
PFE
$141B
| $762K | 0.57% |
21,473
-1,354
| -6% | -$48K |
|
48
Merck
MRK
$213B
| $747K | 0.56% |
13,712
-176
| -1% | -$9.59K |
|
49
Amgen
AMGN
$154B
| $672K | 0.5% |
3,939
| – | – |
|
50
Verizon
VZ
$185B
| $590K | 0.44% |
12,347
+193
| +2% | +$9.22K |
|